Featured News
302Wire StoriesImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration...
- 390Wire Stories
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#AI—SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), announces three software...
- 418Wire Stories
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting
– Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with small cell lung cancer (SCLC) across dose...
- 383Wire Stories
James Hardie Industries plc Announces Proposed Private Offering of Senior Secured Notes
SYDNEY–(BUSINESS WIRE)–James Hardie Industries plc (ASX: JHX) (“James Hardie†or the “Companyâ€) announced today that its wholly-owned subsidiary, JH North America Holdings...
- 303Wire Stories
AEye’s Apollo Lidar Sensor Wins Prestigious AIIA Intelligent Perception Industry Leadership Award
PLEASANTON, Calif.–(BUSINESS WIRE)–AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, announced today that its flagship 1550 nm lidar...
- 351Wire Stories
ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three years First trial in more than a...
- 322Wire Stories
UiPath Partners with HCLTech to Accelerate Agentic Automation for Global Enterprises
NEW YORK & NOIDA, India–(BUSINESS WIRE)–UiPath (NYSE: PATH), a global leader in agentic automation, today announced a strategic partnership with HCLTech, a...
- 406Wire Stories
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#ZenoTOF–At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR),...
- 256Wire Stories
Legrand Strengthens Its Positions as World Champion in Datacenters With the Acquisition of Linkk Busway Systems in Asia
LIMOGES, France–(BUSINESS WIRE)–Regulatory News: Legrand (Paris:LR) is pursuing its active bolt-on acquisition strategy with today’s announcement of Linkk Busway Systems1. Linkk Busway...
- 789Wire Stories
Guidewire Wins Six XCelent Awards and ‘Luminary’ Distinction in Celent’s Regional Reviews of P&C Policy Administration Systems
SAN MATEO, Calif.–(BUSINESS WIRE)–#XCelent–Guidewire (NYSE: GWRE) announced that Guidewire PolicyCenter has been selected as a winner of six Celent XCelent awards and...
- 372Wire Stories
Oyster’s 2025 Global Hiring Report Reveals How the Expertise Economy is Reshaping the World of Work
Contract work surges 46% as professionals pursue autonomy through expertise while companies seek specialized skills on demand Remote-First Company/SAN FRANCISCO–(BUSINESS WIRE)–#HR—Oyster®, the...
